| Literature DB >> 29430551 |
Felipe Kenji Sudo1, Gilberto Sousa Alves2, Denise Madeira Moreira3, Jerson Laks1,4, Eliasz Engelhardt5.
Abstract
BACKGROUND: Staging vascular cognitive impairment (VCI) might be useful for sample selection in clinical trials and for guiding clinical decision-making. Clinical dementia rating (CDR) has been applied for staging cognitive impairments of different etiologies, but it may underestimate severity of non-Alzheimer's disease cognitive deficits.Entities:
Keywords: AD, Alzheimer disease; CAMCOG, Cambridge Cognitive Examination; CDR; CDR, Clinical Dementia Rating; CDR-FUNC, Clinical Dementia Rating — Functional Subsum; CDR-SoB, Clinical Dementia Rating — Sum of Boxes; Cerebrovascular disorders; FAQ, Pfeffer's Functional Activities Questionnaire; MMSE, Mini-Mental State Examination; Subcortical Vascular Dementia; TMT-A, Trail-Making Test Part A; TMT-B, Trail-Making test Part B; VCI, Vascular Cognitive Impairment; VF, Verbal Fluency; VaD, Vascular Dementia; Vascular Cognitive Impairment; Vascular Dementia
Year: 2016 PMID: 29430551 PMCID: PMC5803105 DOI: 10.1016/j.ensci.2016.06.001
Source DB: PubMed Journal: eNeurologicalSci ISSN: 2405-6502
Sociodemographic aspects of the sample.
| Sociodemographic aspects | Range | |
|---|---|---|
| Gender (M/F) | 9/14 | – |
| Age (years) | 72.9 ± 7.5 | 60–90 |
| Schooling (years) | 9.5 ± 5.1 | 4–19 |
| MMSE | 26.3 ± 3.3 | 18–30 |
| CDR (0/0.5/1/2/3) | 4/16/2/1/0 | – |
| CDR-SoB | 2.2 ± 2.5 | 0–11 |
| CDR-FUNC | 1.1 ± 1.6 | 0–7 |
| mF (moderate/severe) | 9/14 | – |
M = male; F = female; MMSE = Mini-Mental State Examination; CDR = Clinical Dementia Rating; CDR-SoB = CDR Sum-of-boxes; CDR-FUNC = CDR Functional Subsum; mF = modified Fazekas Scale.
Spearman's correlations between CDR, CDR-SoB and CDR-FUNC, and scores in cognitive and functional assessment.
| CDR | CDR-SoB | CDR-FUNC | |
|---|---|---|---|
| MMSE | − 0.314 | − 0.611 | − 0.637 |
| CAMCOG | − 0.270 | − 0.513 | − 0.482 |
| FAQ | 0.623 | 0.655 | 0.708 |
| TMT-A | 0.188 | 0.225 | 0.103 |
| ERRORS TMT-A | 0.092 | 0.160 | 0.161 |
| TMT-B | − 0.058 | 0.168 | 0.200 |
| ERRORS TMT-B | − 0.155 | 0.035 | 0.029 |
| TMT B:A | − 0.192 | 0.122 | 0.271 |
| TMT B-A | − 0.062 | 0.223 | 0.265 |
| VF | − 0.065 | − 0.262 | − 0.250 |
| CLOX 1 | − 0.167 | − 0.396 | − 0.359 |
| CLOX 2 | − 0.318 | − 0.472 | − 0.512 |
| CLOX 2:1 | − 0.124 | − 0.010 | − 0.111 |
| WORKING MEMORY | − 0.315 | − 0.494 | − 0.436 |
| ABSTRACTION | − 0.153 | − 0.436 | − 0.449 |
CDR = Clinical Dementia Rating; CDR-SoB = Clinical Dementia Rating- Sum of Boxes; CDR-FUNC = Clinical Dementia Rating – Functional Subsum; MMSE = Mini-Mental State Examination; CAMCOG = Cambridge Cognitive Examination; FAQ = Pfeffer's Functional Activities Questionnaire; TMT-A = Trail-Making Test Part A; TMT-B = Trail-Making test Part B; TMT B:A = Quotient TMT-B/TMT A; TMT B-A = Difference TMT B – TMT A; VF = Verbal Fluency.
p < 0.05.
p < 0.01.